151 related articles for article (PubMed ID: 19530074)
21. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
Cho CW; Choi JS; Yang KH; Shin SC
Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
[TBL] [Abstract][Full Text] [Related]
22. Effects of adhesives and permeation enhancers on the skin permeation of captopril.
Park ES; Chang SJ; Rhee YS; Chi SC
Drug Dev Ind Pharm; 2001 Oct; 27(9):975-80. PubMed ID: 11763476
[TBL] [Abstract][Full Text] [Related]
23. Multiscale study on the enhancing effect and mechanism of borneolum on transdermal permeation of drugs with different log P values and molecular sizes.
Yang C; Guo S; Wu X; Yang P; Han L; Dai X; Shi X
Int J Pharm; 2020 Apr; 580():119225. PubMed ID: 32173500
[TBL] [Abstract][Full Text] [Related]
24. Microemulsions as transdermal drug delivery vehicles.
Kogan A; Garti N
Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
[TBL] [Abstract][Full Text] [Related]
25. Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation.
Gorukanti SR; Li L; Kim KH
Int J Pharm; 1999 Dec; 192(2):159-72. PubMed ID: 10567747
[TBL] [Abstract][Full Text] [Related]
26. Biodegradable derivatives of tranexamic acid as transdermal permeation enhancers.
Vávrová K; Hrabálek A; Dolezal P; Holas T; Klimentová J
J Control Release; 2005 May; 104(1):41-9. PubMed ID: 15866333
[TBL] [Abstract][Full Text] [Related]
27. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
Ameen D; Michniak-Kohn B
Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
29. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
30. Studies on in vitro and in vivo transdermal flux enhancement of methotrexate by a combinational approach in comparison to oral delivery.
Prasad R; Anand S; Khar RK; Dinda AK; Koul V
Drug Dev Ind Pharm; 2009 Nov; 35(11):1281-92. PubMed ID: 19832628
[TBL] [Abstract][Full Text] [Related]
31. Effect of polyunsaturated fatty acids and some conventional penetration enhancers on transdermal delivery of atenolol.
Puglia C; Bonina F
Drug Deliv; 2008 Feb; 15(2):107-12. PubMed ID: 18293196
[TBL] [Abstract][Full Text] [Related]
32. Transdermal delivery of tea catechins and theophylline enhanced by terpenes: a mechanistic study.
Fang JY; Tsai TH; Lin YY; Wong WW; Wang MN; Huang JF
Biol Pharm Bull; 2007 Feb; 30(2):343-9. PubMed ID: 17268077
[TBL] [Abstract][Full Text] [Related]
33. Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin.
Babu RJ; Pandit JK
Drug Deliv; 2005; 12(3):165-9. PubMed ID: 16025846
[TBL] [Abstract][Full Text] [Related]
34. Exploring unsaturated fatty acid cholesteryl esters as transdermal permeation enhancers.
Rambharose S; Kalhapure RS; Jadhav M; Govender T
Drug Deliv Transl Res; 2017 Apr; 7(2):333-345. PubMed ID: 28160257
[TBL] [Abstract][Full Text] [Related]
35. Elastic liposomes mediated transdermal delivery of an anti-jet lag agent: preparation, characterization and in vitro human skin transport study.
Dubey V; Mishra D; Nahar M; Jain NK
Curr Drug Deliv; 2008 Jul; 5(3):199-206. PubMed ID: 18673263
[TBL] [Abstract][Full Text] [Related]
36. The implications of lipid mobility, drug-enhancers (surfactants)-skin interaction, and TRPV1 activation on licorice flavonoid permeability.
Wang Z; Chen H; Liang T; Hu Y; Xue Y; Wu Y; Zeng Q; Zheng Y; Guo Y; Zheng Z; Zhai D; Liang P; Shen C; Jiang C; Liu L; Shen Q; Zhu H; Liu Q
Drug Deliv Transl Res; 2024 Jun; 14(6):1582-1600. PubMed ID: 37980702
[TBL] [Abstract][Full Text] [Related]
37. Design of improved permeation enhancers for transdermal drug delivery.
Godavarthy SS; Yerramsetty KM; Rachakonda VK; Neely BJ; Madihally SV; Robinson RL; Gasem KA
J Pharm Sci; 2009 Nov; 98(11):4085-99. PubMed ID: 19697392
[TBL] [Abstract][Full Text] [Related]
38. Development and biopharmaceutical evaluation of quinupramine-EVA matrix containing penetration enhancer for the enhanced transdermal absorption in rats.
Shin SC; Kim J; Kim WJ; Kim SJ; Cho CW
Pharm Dev Technol; 2007; 12(5):429-36. PubMed ID: 17963142
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the permeation enhancer strategy on benzoylaconitine transdermal patch: the relationship between transdermal enhancement strength and physicochemical properties of permeation enhancer.
Liu C; Farah N; Weng W; Jiao B; Shen M; Fang L
Eur J Pharm Sci; 2019 Oct; 138():105009. PubMed ID: 31306781
[TBL] [Abstract][Full Text] [Related]
40. A Data-Mining Approach for the Quantitative Assessment of Physicochemical Properties of Molecular Compounds in the Skin Flux.
Choi HK; Acharya G; Lee Y; Lee CH
AAPS PharmSciTech; 2021 Mar; 22(3):117. PubMed ID: 33768360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
